There are efficiencies that can be gained by looking for the intersections of data required by different stakeholders. Can we plan our regulatory strategy, submissions and studies such that we can address the needs of FDA and CMS at the same time? Join Jeff Shapiro and David Farber from King & Spalding Law to explore the questions that FDA and CMS (and other payers) share in common and how we can save cost and time by developing a strategy to address them both up front. Jeff and David will provide an overview of issues to consider in product development and clinical testing. Jeff and David are both proponents of unified FDA regulatory and CMS strategies
Email Fogarty Education to inquire about attendance.